A Phase II Trial of Temozolomide for Patients with Recurrent or Progressive Brain Metastases

Overview of attention for article published in Journal of Neuro-Oncology, July 2001

Altmetric Badge

Mentioned by

So far, Altmetric has seen 7 X posts from 6 X users, with an upper bound of 13,590 followers.

RT @JNeurooncol: #ClassicArticle: Abrey and colleagues showed that temozolomide could be effective in treating brain metastases. Before (le…

RT @JNeurooncol: #ClassicArticle: Abrey and colleagues showed that temozolomide could be effective in treating brain metastases. Before (le…

RT @JNeurooncol: #ClassicArticle: Abrey and colleagues showed that temozolomide could be effective in treating brain metastases. Before (le…

RT @JNeurooncol: #ClassicArticle: Abrey and colleagues showed that temozolomide could be effective in treating brain metastases. Before (le…

RT @JNeurooncol: #ClassicArticle: Abrey and colleagues showed that temozolomide could be effective in treating brain metastases. Before (le…

RT @JNeurooncol: #ClassicArticle: Abrey and colleagues showed that temozolomide could be effective in treating brain metastases. Before (le…

#ClassicArticle: Abrey and colleagues showed that temozolomide could be effective in treating brain metastases. Before (left) and after 2 cycles (right). https://t.co/kceLIE8qBG https://t.co/eidqeuSRIQ